When combined with semaglutide 2.4mg, trial data show average weight losses of approximately 1517% over 20 weeks materially exceeding semaglutide monotherapy suggesting strong synergy between amylin and GLP-1 pathways
Several studies have demonstrated that the combination of xCT inhibition with chemotherapy can effectively counteract this chemoresistance
Given its potent redox capabilities, and its high intracellular concentration and widespread distribution, its role as a potent defense mechanism against oxidative and electrophilic stress is well-established
Store lyophilized vials at 20 C until reconstitution
Example conversions using a standard U-100 Insulin Syringe (31G): 0.25mg Dose = 10 Units (0.1mL) 0.5mg Dose = 20 Units (0.2mL) 1.0mg Dose = 40 Units (0.4mL) MEDICAL DISCLAIMER: This product information is for educational purposes only
Nan H, Kraft P, Hunter DJ, Han J